These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 17294110

  • 1. Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial 192Ir HDR brachytherapy.
    Kolotas C, Tselis N, Sommerlad M, Röddiger S, Schnabel T, Baltas D, Kalogera-Fountzila A, Fountzilas G, Zamboglou N.
    Strahlenther Onkol; 2007 Feb; 183(2):69-75. PubMed ID: 17294110
    [Abstract] [Full Text] [Related]

  • 2. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
    Hepel JT, Syed AM, Puthawala A, Sharma A, Frankel P.
    Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1444-50. PubMed ID: 16029806
    [Abstract] [Full Text] [Related]

  • 3. Hypofractionated accelerated CT-guided interstitial ¹⁹²Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer.
    Tselis N, Ratka M, Vogt HG, Kolotas C, Baghi M, Baltas D, Fountzilas G, Georgoulias V, Ackermann H, Zamboglou N.
    Radiother Oncol; 2011 Jan 01; 98(1):57-62. PubMed ID: 21129799
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer.
    Glatzel M, Büntzel J, Schröder D, Küttner K, Fröhlich D.
    Laryngoscope; 2002 Aug 01; 112(8 Pt 1):1366-71. PubMed ID: 12172246
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Short- to mid-term evaluation of CT-guided 125I brachytherapy on recurrent or metastatic head and neck cancers].
    Huang ZL, Li CX, Zhang FJ, Jiao DC, Wu PH, Zhang T, Wang JJ, Duan GF, Wu YX.
    Zhonghua Yi Xue Za Zhi; 2009 Feb 10; 89(5):321-4. PubMed ID: 19563709
    [Abstract] [Full Text] [Related]

  • 9. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy.
    Ricke J, Mohnike K, Pech M, Seidensticker M, Rühl R, Wieners G, Gaffke G, Kropf S, Felix R, Wust P.
    Int J Radiat Oncol Biol Phys; 2010 Oct 01; 78(2):479-85. PubMed ID: 20304566
    [Abstract] [Full Text] [Related]

  • 10. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base.
    Karakoyun-Celik O, Norris CM, Tishler R, Mahadevan A, Clark JR, Goldberg S, Devlin P, Busse PM.
    Head Neck; 2005 May 01; 27(5):353-61. PubMed ID: 15726587
    [Abstract] [Full Text] [Related]

  • 11. Interstitial high dose rate brachytherapy in locally progressive or recurrent head and neck cancer.
    Krüll A, Friedrich RE, Schwarz R, Thurmann H, Schmelzle R, Alberti W.
    Anticancer Res; 1999 May 01; 19(4A):2695-7. PubMed ID: 10470222
    [Abstract] [Full Text] [Related]

  • 12. Reirradiation of locally recurrent nasopharyngeal carcinoma.
    Lengyel E, Baricza K, Somogyi A, Olajos J, Pápai Z, Godény M, Németh G, Esik O.
    Strahlenther Onkol; 2003 May 01; 179(5):298-305. PubMed ID: 12740656
    [Abstract] [Full Text] [Related]

  • 13. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival.
    Mohnike K, Wieners G, Schwartz F, Seidensticker M, Pech M, Ruehl R, Wust P, Lopez-Hänninen E, Gademann G, Peters N, Berg T, Malfertheiner P, Ricke J.
    Int J Radiat Oncol Biol Phys; 2010 Sep 01; 78(1):172-9. PubMed ID: 20056348
    [Abstract] [Full Text] [Related]

  • 14. CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results.
    Tselis N, Kolotas C, Birn G, Röddiger S, Filipowicz I, Kontova M, Fountzilas G, Selviaridis P, Baltas D, Heyd R, Anagnostopoulos G, Zamboglou N.
    Strahlenther Onkol; 2007 Oct 01; 183(10):563-70. PubMed ID: 17896088
    [Abstract] [Full Text] [Related]

  • 15. Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas.
    Schiefke F, Hildebrandt G, Pohlmann S, Heinicke F, Hemprich A, Frerich B.
    J Craniomaxillofac Surg; 2008 Jul 01; 36(5):285-92. PubMed ID: 18353667
    [Abstract] [Full Text] [Related]

  • 16. Interstitial high-dose-rate brachytherapy combined with cervical dissection on head and neck cancer.
    Pellizzon AC, dos Santos Novaes PE, Conte Maia MA, Ferrigno R, Fogarolli R, Salvajoli JV, Kowalski LP.
    Head Neck; 2005 Dec 01; 27(12):1035-41. PubMed ID: 16114005
    [Abstract] [Full Text] [Related]

  • 17. HDR interstitial perineal implant for locally advanced or recurrent uterine cervix cancer.
    Susworo R, Supriana N, Ramli I.
    Radiat Med; 2004 Dec 01; 22(1):2-5. PubMed ID: 15053165
    [Abstract] [Full Text] [Related]

  • 18. Perioperative high-dose-rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Initial results of a Phase I/II reirradiation study.
    Martínez-Monge R, Alcalde J, Concejo C, Cambeiro M, Garrán C.
    Brachytherapy; 2006 Dec 01; 5(1):32-40. PubMed ID: 16563995
    [Abstract] [Full Text] [Related]

  • 19. Feasibility report for retreatment of locally recurrent head-and-neck cancers by combined brachy-chemotherapy using frameless image-guided 3D interstitial brachytherapy.
    Krempien RC, Grehn C, Haag C, Straulino A, Hensley FW, Kotrikova B, Hofele C, Debus J, Harms W.
    Brachytherapy; 2005 Dec 01; 4(2):154-62. PubMed ID: 15893270
    [Abstract] [Full Text] [Related]

  • 20. Intraoperative high dose rate brachytherapy can be used to salvage patients with previously irradiated head and neck recurrences.
    Nag S, Schuller DE, Rodríguez-Villalba S, Martínez-Monge R, Grecula J.
    Rev Med Univ Navarra; 1999 Dec 01; 43(2):56-61. PubMed ID: 11256004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.